Evaluating closed-loop treatment for atrial fibrillation
Official title: Application of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population in the Northern Shanghai Community
Run by Shanghai 10th People's Hospital · NCT05311137 · Data updated 2026-11-12
This study tests a new treatment method for people with atrial fibrillation to see if it can improve their care and health outcomes after undergoing a specific heart procedure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Shanghai 10th People's Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | May 1, 2022 |
| Main results expected | January 1, 2024 |
| Study ends | January 1, 2032 |
| Registry record updated | May 24, 2022 |
| Trial ID | NCT05311137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with atrial fibrillation who can understand and sign informed consent.
✕Probably not a fit
Patients who do not have atrial fibrillation or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a closed-loop treatment approach for patients with atrial fibrillation, focusing on optimizing treatment strategies and improving disease outcomes. It aims to enhance patient understanding of atrial fibrillation and assess the economic implications of this treatment concept within the northern Shanghai community. The study involves monitoring patients who undergo radiofrequency ablation as part of their treatment plan.
Why it matters
Potential benefit: If successful, this approach could lead to improved management and outcomes for patients with atrial fibrillation.
How similar studies have gone: While the concept of closed-loop treatment is innovative, similar approaches in managing atrial fibrillation have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * atrial fibrillation patients;Ability to act autonomously, understand and sign informed consent; Exclusion Criteria: * none(All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up)
Where it's running
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: DongDong Zhao, PhD
- Email: zhaodd@tongji.edu.cn
- Phone: +86 18917684008
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
-
Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation
This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.
-
Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II
This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.
-
4D intracardiac echocardiography to guide left atrial appendage occlusion procedures
A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.
-
Thoracoscopic vs Catheter Ablation as the First Rhythm Control in Atrial Fibrillation with a Large Left Atrium
This trial tests whether thoracoscopic surgical ablation is better at keeping atrial fibrillation under control than catheter ablation in people with persistent AF and a large left atrium who have not had an ablation before.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.